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Abstract: 
Third molar extraction is one of the most frequent intervention in dentistry. 
Nevertheless, there is scarce evidence on the host response of individuals 
with impacted or semi-impacted third molars and the possible effects of 
surgical removal. A case-control study of 40 patients was designed to 
evaluate 1) the differences in biomarkers of systemic inflammation, 
vascular function and metabolism (high sensitive C-reactive protein, lipids, 
fibrinogen, oxidative stress and endothelial function analysis) and 2) the 
acute and short-term effects of surgical removal between patients with 
bilateral impacted or semi-impacted third molars compared to controls with 
no third molars.  
Patients undergoing third molar extraction exhibited greater levels of 
systemic inflammation, oxidative stress and triglycerides than controls. 
Raised white cell counts as well as peaks of serum levels of C-reactive 
protein and fibrinogen were noticed in the first post-operative week. Three 
months after the extraction, all markers returned to baseline values. 
Malondialdehyde, an indicator of oxidative stress indicator, was 
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significantly reduced after third molar removal.  
Semi-impacted or impacted third molars are associated with higher 
systemic inflammation and their removal may represent a useful human 
model to study acute inflammation and determine beneficial systemic 
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Third molar extraction is one of the most frequent intervention in dentistry. Nevertheless, there 
is scarce evidence on the host response of individuals with impacted or semi-impacted third 
molars and the possible effects of surgical removal. A case-control study of 40 patients was 
designed to evaluate 1) the differences in biomarkers of systemic inflammation, vascular 
function and metabolism (high sensitive C-reactive protein, lipids, fibrinogen, oxidative stress and 
endothelial function analysis) and 2) the acute and short-term effects of surgical removal 
between patients with bilateral impacted or semi-impacted third molars compared to controls 
with no third molars.  
Patients undergoing third molar extraction exhibited greater levels of systemic inflammation, 
oxidative stress and triglycerides than controls. Raised white cell counts as well as peaks of 
serum levels of C-reactive protein and fibrinogen were noticed in the first post-operative week. 
Three months after the extraction, all markers returned to baseline values. Malondialdehyde, an 
indicator of oxidative stress indicator, was significantly reduced after third molar removal.  
Semi-impacted or impacted third molars are associated with higher systemic inflammation and 
their removal may represent a useful human model to study acute inflammation and determine 
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Surgical extraction of lower third molars is the most frequent intervention in oral surgery 
(Shepherd and Brickley 1994). This procedure it is often associated with important post-surgical 
sequelae mainly of inflammatory nature (Mercier and Precious 1992). Nonetheless, little is 
known about the potential impact of surgical extraction of lower third molars on systemic 
inflammation. 
Systemic inflammation has been implicated in the pathogenesis of many chronic conditions 
including cardiovascular disease and diabetes: a bulk of evidence links small changes of 
inflammatory biomarkers with increased future risk of vascular disease and mortality (Emerging 
Risk Factors Collaboration et al. 2010). Further, even transient increase of systemic inflammation 
may result in an increased risk of vascular events (Smeeth et al. 2004). Interestingly, simple 
medical procedures are associated with increased risk of acute vascular events in the post-
operative period and the perturbation of the body inflammatory level is thought to be a plausible 
triggering mechanism (Mamode et al. 1995).   
Recently, our group preliminary assessed the effects of lower third molars removal on systemic 
inflammation measured by serum levels of inflammatory biomarkers (Cei et al. 2012). Our 
findings indicated a mild inflammatory response of one-week duration characterized by increase 
in serum C-reactive protein, fibrinogen and leukocyte counts after third molar extraction. This 
offered the opportunity to study the third molar removal as a model of human inflammation and 
vascular dysfunction. Nevertheless, the preliminary study lacked a control group and raised 
several questions including whether the changes observed were due to a Hawthorne effect.   
The aims of this study were: 1) to characterize the host response differences between individuals 
with or without lower third molar impaction and 2) to evaluate the effects of their surgical 
removal on biomarkers of systemic inflammation and endothelial function.  
 
Materials and Methods 
Experimental design and patients selection 
This was a single-center case-control clinical trial with a 3-months follow-up designed according 
to STROBE guidelines. The study was approved by the local ethical committee, registered 
Page 4 of 26
http://mc.manuscriptcentral.com/jdr






























































(NCT03048175) and it was conducted according to the declaration of Helsinki on 
experimentation involving humans.  
Eligible study participants were identified among referrals for third molar extraction to the Unit 
of Dentistry and Oral Surgery of the University Hospital of Pisa (Italy). All participants gave 
written informed consent. Full medical and dental histories were recorded and the oral 
examination completed by experienced clinicians. A radiographic analysis was undertaken using 
an ortopantomogram.  
Individuals were excluded if (a) younger than 18 years and older than 65 years; (b) females being 
pregnant or during lactation ; (c) females using contraceptive methods; (d) suffering from any 
reported systemic illness; (e) chronic use of any medication within 30 days prior to the study 
inclusion (f) affected by periodontitis (radiographic diagnosis of vertical bone defects or bone 
resorption equal to 20% of the root length); (g) periapical and periradicular radiolucencies were 
detected on X-rays; (h) unable to participate into the study.  
Control Group  
Twenty consecutive patients, satisfying the inclusion criteria, referred to Unit of Dentistry and 
Oral Surgery, for caries, were invited to participate to the trial as a control group. Probands 
showed hypodontia/previous extraction or no pathologies affecting the lower third molars.  
Tooth removal group  
Twenty patients were enrolled in the tooth extraction group if presenting with a clinical 
indication for the bilateral surgical removal of mandibular third molars i.e. recurrent 
pericoronitis, caries, orthodontic reasons or pathological damage to the second molar. Surgery 
was performed by an experienced surgeon as previously described (Graziani et al. 2006). Briefly, 
after administering inferior dental and buccal nerve anesthesia, a triangular full thickness flap 
with a releasing incision on the mesio-buccal aspect of the second molar was designed. 
Ostectomy was then performed and the third molar was sectioned and gently elevated. Once all 
the tooth components were removed, the socket was carefully inspected and the flap sutured 
with single interrupted sutures. Duration of the surgery and ostectomy was recorded. Sutures 
were removed 7 days after surgical intervention. All patients were given post-operative 
instructions after the surgical intervention. A standard antibiotic therapy (amoxicillin and 
clavulanic acid, 2 g/die, 1 every 12h) for 5 days was prescribed. Penicillin-allergic participants 
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were administered azithromycin 500mg/day for 3 days. Thirty days after the first surgical 
removal patients underwent the contralateral third molar extraction.  
Examinations 
Control group patients were examined at baseline and after 90 days (Fig. 1). At both visits blood, 
clinical and vascular parameters were collected. Tooth removal group patients were examined 
prior the first surgical procedure and all study parameters were collected. Thirty days after the 
first intervention, the contralateral third molar was extracted and new blood, clinical and 
vascular parameters were collected at 24 hours, and 7 and 90 days after the tooth removal.  
Biomarkers analyses 
Serum samples were collected from venipuncture of the antecubital fossa before 8.15 AM after 
an overnight fast for all patients. Blood samples were immediately processed and serum aliquots 
were then stored at -80C°. Serum markers of systemic inflammation assessed included: C-
reactive protein (immuno-turbidimetric assay), fibrinogen (Clauss method) and White Cell 
Leucocyte Counts. All biomarkers were quantified using high-sensitivity assays. Oxidative stress 
was evaluated by measurement of plasma malondialdehyde by spectrophotometric assay 
(Esterbauer  and Cheeseman 1990) and plasma lipoperoxides with a colorimetric method, as 
previously described (Jiang et al. 1992). Antioxidant capacity was measured as plasma total 
antioxidant capability by measuring ferric-reducing antioxidant power (spectrophotometric 
assay) (Benzie and Strain 1996).  
Vascular Parameters 
Participants were all examined at the Hypertension Unit after a 12-hour fasting period for arterial 
blood pressure measurement and vascular assessment. All measurements were taken in a quiet 
air-conditioned room (22-24°C). Patients were asked to refrain from smoking and drinking 
caffeine during the six hours prior to the assessment. 
Averaged triplicate brachial blood pressure measurements at 2-min intervals with patients 
resting in supine position for at least 10 min were performed by using an automatic oscillometric 
device (OMRON-705IT, Omron, Kyoto, Japan).  
Arterial stiffness was assessed as carotid to femoral pulse wave velocity and central 
augmentation index. Arterial tonometry (SphygmoCor, AtCor Medical, Sydney, NSW, Australia) 
was performed according to international recommendations (Laurent et al. 2006). Carotid to 
femoral pulse wave velocity was assessed sequentially recording pressure waveforms at the 
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femoral and carotid site. Pulse wave velocity was calculated as the ratio of the surface distance 
between the two recording sites (subtracting the carotid-sternal notch distance from the 
femoral-sternal notch distance) and wave transit time. Transit time was estimated by the foot-to-
foot (foot of the wave coincides with the systole beginning) method.  
Central blood pressure values were obtained by tonomery from radial pressure waveform 
analysis based on a validated transfer function. Two consecutive measurements were recorded 
and averaged.  
Endothelium-dependent response was assessed as flow-mediated dilation of the brachial artery 
using high resolution ultrasound as previously described (Ghiadoni et al. 2008; Bruno et al. 2012). 
Briefly, a B-mode scan of the right brachial artery was obtained in the longitudinal section 
between 5 cm and 10 cm above the elbow, with the probe held by a stereotactic clamp to ensure 
steady recordings. A pediatric cuff was placed around the forearm below the elbow, inflated for 
5 min at 300mmHg, and then deflated to induce reactive hyperemia. Endothelium-independent 
was obtained by sublingual administration of a 25 μg of glyceryl trinitrate. Vessel diameter was 
measured using a real-time computerized edge detection system. Flow-mediated dilation and 
response to glyceryl trinitrate were calculated as maximal percentage increase in diameter above 
baseline. The intra-observer coefficient of variation for repeated flow-mediated dilation 
measurements was 14%. Arterial blood flow velocity was determined by pulsed Doppler signal at 
70° angle, with the range gate in the center of the artery and measured at baseline and within 
15s after cuff release (peak local shear stress calculated as 8*blood viscosity*mean flow 
velocity/brachial artery diameter, assuming that blood viscosity was 0.0035 Pa*s) (Mitchell et al. 
2004). Vascular parameters were performed at baseline and 90 days in both study groups. Tooth 
removal group patients had these measurements taken at 31,37 days.  
Clinical Oral Parameters 
A single calibrated examiner recorded: probing pocket depth at the distal surface of the second 
lower molar, facial edema, trismus, and pain. Facial edema was evaluated by measuring the 
distance from the corner of the of the mouth to the attachment of the ear lobe following the 
bulge of the cheek, and the distance from the outer canthus of the eye to the angle of the 
mandible as previously described (Graziani et al. 2006). Trismus was the difference in inter-incisal 
distance at maximum opening (Ustün et al. 2003). Patients’ pain perception was assessed via a 
simplified visual analogue scale of 100mm in length with “0” representing “no pain” up to “100” 
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considered as the “most severe pain imaginable”. This scale was further subdivided into four 
intervals (0-25 mm=no pain, 26-50= mild pain, 51-75=moderate pain, 76-100=maximum pain).  
Statistical analysis 
Data was entered, checked for errors and imported in a statistical software package (SPSS, IBM, 
Ver 23). Data is presented as mean and standard errors unless specified. Case-control 
comparisons were performed between study groups using Anova or Chi square statistics. If data 
was not normally distributed (even after log-transformations) equivalent comparative tests were 
used. Multivariate models were constructed using linear regression when statistical differences 
were observed (all models were adjusted for age, gender, BMI and smoking differences). 
Comparison of inflammat ry and vascular function parameters between study groups at baseline 
and 3 months were performed using a two-way ANOVA analysis (group and time), covariate in 
the models included age, gender, smoking and BMI values at baseline. Relative change 
differences were calculated subtracting follow-up values from the baseline/baseline and 
multiplied by 100 [example on C-reactive protein levels at day 1 after surgery: ((C-reactive 
protein day 1 - C-reactive protein at baseline)*100)/ C-reactive protein baseline].  
Acute changes in inflammatory and vascular function biomarkers were compared between study 
visits in the test group by repeated ANOVA (baseline, day1, day7 and 3 months) as previously 
described (D’Aiuto et al. 2005). Correlation analyses between continuous outcomes were 
performed by Spearman rank tests. A p value less than 0.05 was deemed statistically significant. 
The sample size calculation was based a pilot study (Cei et al. 2012) on acute increases of serum 
C-reactive protein following third molar removal. A minimum of 17 patients were needed to 
detect a 3.9 mg/l difference in serum C-reactive protein levels after 24 h (90% power, a 0.05, 
standard deviation of 4mg/l). A final sample of 20 participants per group was planned including a 
10% drop-out rate.  
 
Results 
Population characteristics at baseline 
Cases were balanced for age, smoking and BMI differences compared to controls with a slight 
imbalance for gender distribution (Table 1). When local inflammation was recorded at the 
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gingival tissue surrounding semi-impacted third molars, it was also associated with a state of low-
grade systemic inflammation and dyslipidemia. Indeed, statistically significant higher systemic 
concentrations in triglycerides, C-reactive protein, fibrinogen and malondialdehyde were 
observed in tooth removal group patients versus controls. No substantial differences were 
however found for all measures of vascular function and arterial distensibility. All patients 
completed the study with no loss to follow-up.  
Inflammatory markers, Oxidative Stress and Cardiovascular Parameters 
In the control group, no changes of systemic parameters/biomarkers were noted (Fig. 2 & Tab.2). 
Three months after the removal of the last impacted third molar, there were however reductions 
in C-reactive protein, fibrinogen and plasma lipoperoxides in tooth removal group patients versus 
controls but they did not reach statistical significance. Nevertheless, patients in the tooth 
removal group exhibited a statistically significant reduction (-17% versus 66%, p=0.035) of serum 
malondialdehyde levels when compared to controls (Appendix 1).  
Following the extraction of third molars a mild systemic inflammation was observed during the 
first week. Statistically significant changes were observed for white blood cells (p<0.001), C-
reactive protein (p=0.004), fibrinogen (p<0.001), plasma lipoperoxides (p=0.001) and ferric-
reducing antioxidant power (p=0.002). An acute increase in Neutrophil counts and reduction in 
Lymphocytes were observed 24 hours following the surgical intervention (Fig. 2). Similarly, acute 
increases in C-reactive protein and fibrinogen were observed over the first week (with a peak 
one week after) following the dental extraction (Fig. 2). At 3 months, C-reactive protein levels 
were higher than baseline whilst fibrinogen levels were lower than baseline (Appendix 2). A 
strong positive linear correlation was confirmed for C-reactive protein with both fibrinogen 
(R=0.4, p=0.007) and white blood cells (R=0.4, p=0.035).  
An altered oxidative status was observed in patients especially with regards to the ferric-
reducing antioxidant power activity. Indeed, a statistically significant reduction was observed 
24hrs and 1 week following the dental procedure. A strong positive correlation was found 
between fibrinogen and plasma lipoperoxides (R=0.4, p=0.011). No substantial correlation was 
observed between the serum levels, relative increase from baseline of acute phase and oxidative 
markers with intra-surgical measurements (ostectomy and surgery time, socket dimension, 
distance from CEJ and alveolar bone) (data not shown). The only exception was a strong negative 
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correlation between recorded facial edema 7 days after third molar removal and relative 
increase of fibrinogen levels (R=-0.7, p=0.02). 
A non-statistically significant reduction in flow-mediated dilation was observed during the acute 
inflammatory response. Flow-mediated dilation tended to be lower than baseline at one week 
follow-up after the second third molar removal when post-hoc multiple comparisons were made. 
A different trend was observed for response to glyceryl trinitrate (p=0.07). GTN was significantly 
reduced in comparison to baseline, 1 day after the second tooth extraction. Pulse wave velocity 
and central augmentation index remained unchanged throughout the study.  
Flow-mediated dilation and GTN response in tooth removal group patients and controls were not 
different at baseline and after three months (p for interaction time per group 0.17 for flow-
mediated dilation and 0.87 for glyceryl trinitrate). No differences were found for the other 
vascular parameters (data not shown). A moderate negative correlation was observed between 
ferric-reducing antioxidant power and flow-mediated dilation (R=0.3, p=0.038). 
Oral Clinical Parameters 
All third molars examined were partially impacted except for two cases with osteo-mucosal 
inclusion and no clinical communication with the oral cavity. At baseline patients presented with 
spontaneous (N=12) or triggered (N=9) pain, pus discharge (N=5), local inflammation (N=14) and 
some lympho-adenopathy (N=10). During the first post-operative period, ostectomy time 
correlated with development of edema on the first day after surgery (R=0.6, p=0.03). Patients 
presenting with pre-existing local inflammation around third molars experienced greater pain 
scores the day after the extraction (visual analogue scale scores from 52±15 to 29±20 and an 
average difference of 24, 95%CI 1-47, p=0.04). A statistically significant reduction in pocket 
probing depth between baseline and 3 months was detected on the distal aspect of the second 
molar in the tooth removal group (from  3.5±0.6mm to 2.9±0.5mm, with an average 0.6 mm 
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This case-control study indicated that patients in need of third molar extraction exhibited higher 
levels of systemic inflammation, oxidative stress and lower lipid fractions when compared to 
controls. Further, following the extraction of third molar a modest inflammatory response is 
mounted and sustained up to 1 week. Three months after tooth removal all biomarkers returned 
to values similar to baseline. No changes in endothelial function were observed. A modest impact 
of the post-surgical inflammation was observed for both endothelium-dependent and -
independent vasodilation.  
Third molar presence/pathology may be associated with systemic inflammation and an alteration 
of the overall patients’ wellbeing. Indeed, the presence of third molars is associated with higher 
levels of C-reactive protein and IL-6 compared to patients with no visible third molars 
(Offenbacher et al. 2012). Moreover, young pregnant females with the presence of third molars 
exhibit more periodontitis and this may ultimately account for the higher level of systemic 
inflammation (Moss et al. 2007).  
The baseline level of C-reactive protein in the tooth removal group was higher than the expected 
values reported in non-smokers healthy controls of same age and similar to those observed in 
patients with periodontitis (Tonetti et al. 2007). This host response linked to third molar was 
characterized by the high level of fibrinogen and malondialdehyde, indicating a higher systemic 
oxidative stress. Nevertheless, in this study we noted no impairment of vascular function 
between tooth removal patients and controls. One possible explanation for this discrepancy 
could be that the exposure to inflammation and oxidative stress is too short to determine a 
significant endothelial dysfunction especially as patients were all young individuals with a low 
cardiovascular risk profile. Alternatively, the inflammatory response associated with the 
impaction of third molar might be of insufficient magnitude to trigger endothelial dysfunction.  
The first week following tooth removal was characterized by peaks of blood cells count, C-
reactive protein and fibrinogen. This had been noted in the immediate post-surgical days in 
patients with high levels of systemic inflammation at baseline (Chander et al. 2013). Our data are 
also in agreement with previous evidences of the systemic impact of periodontal treatment. 
Indeed, periodontal treatment, both non-surgical and surgical, determine a moderate response 
of the systemic inflammation as shown by an increase of C-reactive protein and other systemic 
inflammatory bio-markers 24 hours after treatment (D’Aiuto et al. 2004; Graziani et al. 2010; 
Graziani et al. 2015). However the host response following tooth removal is still detected at day 
7 whereas periodontal treatment triggers a faster but greater systemic inflammatory response. 
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We can only speculate on the possible reasons behind these differences. Following periodontal 
treatment, the systemic inflammatory response is likely to be determined by both bacteremia 
and local tissue trauma which ultimately may determine a release of inflammatory mediators 
and acute-phase proteins (Birkedal-Hansen 1993; Gabay and Kushner 1999). In the periodontal 
model, non-surgical periodontal treatment determines a higher level of post-operative 
inflammation compared to surgical. This might be because periodontal surgery is usually 
performed in a previously decontaminated area. Conversely, third molar surgery is usually 
performed in a non-decontaminated wound (Rajasuo et al. 2004). It is also true that using not 
specific markers of systemic inflammation in both models does not allow interpretation of how 
much the local inflammation would contribute to the overall inflammatory burden and how 
much this is produced by the surgical trauma. Further research using more specific biomarkers 
linked to the local infectious inflammatory burden should be performed. 
An association between oral and atherosclerotic inflammation has been reported (Subramanian 
et al. 2013). In this study the low-magnitude acute inflammatory response following the surgical 
procedure confirms the modest reduction of endothelium-dependent vasodilation observed 
when compared to that observed following whole mouth non-surgical periodontal treatment 
(Tonetti et al. 2007). A trend to reduction in endothelium-independent vasodilation in the 
brachial artery was noted. Although a time-dependent reduction in glyceryl trinitrate was 
reported, this finding did not reach statistical significance. It is conceivable that the methodology 
used (low-dose nitrates) produced a degree of vasodilation similar to that of flow-mediated 
dilation, did not allow detection of subtle differences in the acute phase following tooth removal. 
This study findings suggest that smooth muscle function may be compromised by acute 
inflammation and this should be further investigated. 
Removal of third molar might have also a mid-term systemic beneficial effect as assessed by a 
reduction of malondialdehyde. Conversely, endothelial function did not improve at the final 
evaluation. This apparent discrepancy with other models of oral inflammation may be explained 
with the apparent better health status and younger age of our study population, lesser duration 
of exposure to chronic inflammation and shorter follow – up period for vascular assessment. 
Lastly, the removal of the third molar determines consistent post-surgical sequelae affecting the 
oral cavity and facial tissues in the immediate days following the surgery. The time spent 
intrasurgically to remove bone correlates with the amount of post-surgical edema and this is 
consistent with previous data reported by our group (Graziani et al. 2006). Interestingly, the 
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facial edema observed following third molar removal was also correlated with fibrinogen serum 
levels post tooth removal as further confirmation of an important relationship between local and 
systemic inflammation.  
The authors are aware of the strengths and limitations of the study. On the one hand 
information on the bacteremia following the tooth removal might have helped in clarifying 
possible sources of the host response. A non-randomized design and limited follow-up are 
recognized as limitations of the study. On the other hand, a larger array of biomarkers of 
systemic inflammation and vascular parameters used in the study provides evidence for a novel 
model to study systemic inflammation in humans.  
In conclusion, third molar removal is associated with a transient systemic inflammatory response 
of one-week duration. Three months after third molars removal, a reduction in oxidative stress is 
observed. Conversely, endothelial function was not affected by the presence and removal of 
third molars. The potential systemic benefits of third molars removal merits further 
investigation.  
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Figure 1 Study Design 
 
Figure 2. Mean (SE) changes in white blood cells (WBC) (Fig. 2a), Neutrophils (Fig. 2b), 
Lymphocytes counts (Fig. 2c), C-reactive protein (CRP) (Fig. 2d), fibrinogen (Fig. 2e), flow-
mediated dilation (FMD) (Fig. 2f), malondialdehyde (MDA) (Fig. 2g), plasma lipoperoxides 
(LOOH)(Fig. 2h), ferric-reducing antioxidant power (FRAP) (Fig. 2i) in both tooth extraction and 
control group.  Stars indicated statistically significant differences from baseline.  
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Table 1.  
Case control comparison at baseline 
 







Age, years 25±5 26±4 0.480 
Gender, Male (%) 7(35) 14(70%) 0.06 
Smoking, current (%) 7(35%) 8(40%) 1.0 
BMI, kg/m2 22.4±4.4 21.8±2.3 0.559 
WBC,103 cells/ml 6.94±2.53 6.23±1.16 0.725 
Systolic BP, mmHg 120.90±14.97 125.15±12.39 0.311 
Diastolic BP, mmHg 67.80±8.62 66.90±9.34 0.690 
Cholesterol, mmol/l 178.50±33.10 174.60±39.91 0.603 
HDL, mmol/l 53.85±12.42 60.10±18.64 0.354 
Triglycerides, mmol/l 105.15±30.80  81.45±36.19 0.016 
Glucose, mmol/l 81.35±12.21 67.55±30.25 0.104 
AIx @75 bpm -5.4±13.4 4.1±17.3 0.979 
PWV (carotid_femoral),% 5.60±0.80 5.57±0.81 0.748 
FMD, % 8.25±3.15 7.36±3.09 0.297 
RH, % 660.65±374.92 504.76±411.65 0.096 
GTN, % 8.30±3.68 7.16±2.16 0.255 
CRP, mg/l 3.42±5.62 0.93±1.05 0.028 
Fibrinogen, g/dl 255.70±64.86 226.65±46.28 0.038 
MDA, µmol/l 2.68±1.13 1.49±0.91 <0.001 
LOOH, µmol/l 2.00±2.20 1.47±4.67 0.547 
FRAP, mmol/l 673±181 644±156 0.642 
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Mean values (± SD) of study parameters in the control (first line) and tooth removal (second line) groups 
at Baseline and 3 months. P-value refers to the difference between study groups after 3 months. 
 
Variable Baseline 3 Months p value 
Red cells, 10
6








 cells/ml 271.95±59.83 278.35±66.56 0.499 
266.75±59.58 251.94±66.35 
Fibrinogen, g/dl 226.65±46.28 255.70±64.86 0.304 
227.35±54.38 237.15±61.72 
Cholesterol, mmol/l 174.60±39.91 178.50±33.10 0.894 
174.65±36.85 178.12±37.18 
HDL, mmol/l 60.10±18.64 53.85±12.42 0.053 
54.80±12.83 58.23±11.34 
Triglycerides, mmol/l 81.45±36.19 105.15±30.80 0.624 
107.60±31.92 91.06±58.50 
Glucose, mmol/l 67.55±30.25 81.35±12.21 0.311 
64.90±36.21 83.00±8.03 
Ca 85.25±7.24 9.55±.57 0.885 
84.90±6.27 9.56±.44 
CL 11.73±9.25 104.82±3.24 0.511 
9.63±0.30 103.18±4.02 
Na 141.30±1.78 140.00±2.08 0.621 
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K 4.00±.21 3.97±.29 0.852 
4.05±0.31 3.97±.25 
Systolic BP, mmHg 125.15±12.39 120.90±14.97 0.918 
121.60±7.84 117.83±13.01 
Dyastolic BP, mmHg 66.90±9.34 67.80±8.62 0.624 
65.25±7.76 65.61±7.44 
PWV (carotid_femoral),% 5.57±0.81 5.60±0.80 0.405 
5.62±0.57 5.74±1.80 
FMD, % 7.36±3.09 8.25±3.15 0.323 
7.03±2.39 7.03±2.74 
RH, % 504.76±411.65 660.65±374.92 0.221 
339.87±247.62 603.01±427.85 
GTN, % 7.16±2.16 8.30±3.68 0.729 
7.15±2.34 7.97±4.08 
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Mean (SE) changes in white blood cells (WBC) (Fig. 2a), Neutrophils (Fig. 2b), Lymphocytes counts (Fig. 
2c), C-reactive protein (CRP) (Fig. 2d), fibrinogen (Fig. 2e), flow-mediated dilation (FMD) (Fig. 2f), 
malondialdehyde (MDA) (Fig. 2g), plasma lipoperoxides (LOOH)(Fig. 2h), ferric-reducing antioxidant power 
(FRAP) (Fig. 2i) in both tooth extraction and control group.  Stars indicated statistically significant 
 differences from baseline.   
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Relative changes of CRP within the tooth extraction group  
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